81348 Srsf2 gene common variants
Also known as: SRSF2 variant testing, splicing factor mutation analysis
Serine/Arginine-Rich Splicing Factor 2 (SRSF2) gene analysis for common variants in hematologic malignancies.
In Plain Language
Blood cancer mutation test; Myelodysplastic syndrome marker
Clinical Context
Detects SRSF2 mutations in myelodysplastic syndrome and acute myeloid leukemia for prognosis and treatment planning.
RVU Information
CPT 81348 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81348?
CPT 81348 (Srsf2 gene common variants) is a Pathology & Lab code. Serine/Arginine-Rich Splicing Factor 2 (SRSF2) gene analysis for common variants in hematologic malignancies.
Who uses CPT code 81348?
CPT 81348 is used by Pathology, Hematology, Oncology. Detects SRSF2 mutations in myelodysplastic syndrome and acute myeloid leukemia for prognosis and treatment planning.
When is CPT 81348 used?
Detects SRSF2 mutations in myelodysplastic syndrome and acute myeloid leukemia for prognosis and treatment planning.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.